Trial Site Detail
Drug: |
DCC-3116 + Ripretinib |
|||
|---|---|---|---|---|
Trial: |
A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
New York University550 First Avenue |
Principal Investigator: |
|
|---|---|
Contact: |
Contact: Phase 1 Screening 212-731-5654 Phase1Screening@nyulangone.org |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
New York University Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.